These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 17998316)

  • 21. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
    Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
    Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI.
    Cao WM; Murao K; Imachi H; Yu X; Dobashi H; Yoshida K; Muraoka T; Kotsuna N; Nagao S; Wong NC; Ishida T
    Endocrinology; 2004 Dec; 145(12):5540-7. PubMed ID: 15345670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
    Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
    Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLRs antiviral effect on hepatitis B virus in HepG2 cells.
    Xia C; Lu M; Zhang Z; Meng Z; Zhang Z; Shi C
    J Appl Microbiol; 2008 Nov; 105(5):1720-7. PubMed ID: 19149768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
    Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
    Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV].
    Zhang Q; Wei L; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
    Metz P; Dazert E; Ruggieri A; Mazur J; Kaderali L; Kaul A; Zeuge U; Windisch MP; Trippler M; Lohmann V; Binder M; Frese M; Bartenschlager R
    Hepatology; 2012 Dec; 56(6):2082-93. PubMed ID: 22711689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host cell responses induced by hepatitis C virus binding.
    Fang X; Zeisel MB; Wilpert J; Gissler B; Thimme R; Kreutz C; Maiwald T; Timmer J; Kern WV; Donauer J; Geyer M; Walz G; Depla E; von Weizsäcker F; Blum HE; Baumert TF
    Hepatology; 2006 Jun; 43(6):1326-36. PubMed ID: 16729312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interference with ERK and STAT signaling pathways and inhibition of hepatitis C virus replication by ribavirin.
    Zhao LJ; Wang W; Liu Y; Ren H; Qi ZT
    Antiviral Res; 2012 Nov; 96(2):260-8. PubMed ID: 22985631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-alpha.
    Ikeda M; Mori K; Ariumi Y; Dansako H; Kato N
    FEBS Lett; 2009 May; 583(9):1434-8. PubMed ID: 19332062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human scavenger receptor B1 on and in human platelets.
    Imachi H; Murao K; Cao W; Tada S; Taminato T; Wong NC; Takahara J; Ishida T
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):898-904. PubMed ID: 12649086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of interferon-α signaling by hepatitis E virus.
    Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
    Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.